ADAR1 Capital Management »

Lexaria Bioscience shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Lexaria Bioscience (LEXX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Lexaria Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Lexaria Bioscience held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexaria Bioscience by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $97k 27k 3.63
2023-12-31 $2.0k 1.6k 1.25

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Lexaria Bioscience

Armistice Capital
Invenomic Capital Management
Geode Capital Management
Vanguard Group
GenTrust
Raymond James Financial Services Advisors
State Street Corporation
BlackRock
BlackRock
Welch Group
Morgan Stanley
Northern Trust
Wealth Enhancement Advisory Services
Hrt Financial
Royal Bank of Canada

View all funds holding Lexaria Bioscience